Primary cutaneous anaplastic large cell lymphoma

Name
Primary cutaneous anaplastic large cell lymphoma
ICD-O-3 Morphology
9718/3
Effective 2001 and later
Reportable
for cases diagnosed 2001 and later
Primary Site(s)
C440-C449, C510-C512, C518-C519, C600-C602, C608-C609, C632

Help me code for diagnosis year :

Grade
5 - T-cell
Module Rule
None
Alternate Names
C-ALCL
Primary cutaneous CD30+ large T-cell lymphoma
Primary cutaneous CD30+ T-cell lymphoproliferative disorder
Definition
A spectrum of cutaneous lymphoproliferative diseases: Primary cutaneous anaplastic large cell lymphoma (C-ALCL); Lymphomatoid papulosis; borderline lesions in which a definite distinction between C-ALCL and lymphomatoid papulosis cannot be made. A spectrum of related conditions originating from transformed or activated CD30+ T lymphocytes. Distinction of C-ALCL from systemic ALCL with cutaneous involvement is important. This is part of the Primary cutaneous CD30 positive T-cell lymphoproliferative disorders WHO group, which also includes lymphomatoid papulosis (see 9718/1).
Abstractor Notes
Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is one of two primary cutaneous CD30-positive T-cell lymphoproliferative disorders. (The other disorder, lymphomatoid papulosis [9718/1], is not reportable for cases diagnosed in 2010 and forward.) C-ALCL most frequently affects the skin of the trunk, face, extremities, and buttocks. Most patients present with solitary or localized nodules or tumors, and sometimes papules, and often show ulceration. Multifocal lesions are seen in about 20% of cases. These lymphomas frequently relapse in the skin. Extracutaneous dissemination occurs in <10% of the patients and mainly involves the lymph nodes. The prognosis is usually favorable with a 10-year disease-related survival of approximately 90%.
Definitive Diagnostic Methods
Histological confirmation
Immunophenotype
Genetics Data
T-cell receptor (TCR) genes are clonally rearranged
Immunophenotyping
CD2-
CD4+ T-cell phenotype
CD30+
Most express cutaneous lymphomacyte antigen (CLA)
Treatments
Chemotherapy
Radiation
Transformations to
No Transformations
Transformations from
No Transformations
Corresponding ICD-9 Codes
202.7 Peripheral T-cell lymphoma
Corresponding ICD-10 Codes
C84.4 Peripheral T-cell lymphoma
Corresponding ICD-10-CM Codes (effective October 1, 2015 U.S. only)
C86.6 Primary cutaneous CD30-positive T-cell proliferations
Signs and Symptoms
None
Diagnostic Exams
None
Recurrence and Metastases
None
Epidemiology and Mortality
None